Colin Drummond of Case Western Reserve University’s department of biomedical engineering discussed a few of the most promising medical technology spinoff companies from the university.
As director of the Coulter-Case Translational Research Partnership, Drummond is behind a $1 million fund that often invests in technologies spun out of Case.
Drummond discusses a few spinoff companies, including next-generation insulin developer Thermalin Diabetes and stroke device start Swallowing Solutions.
With the Rise of AI, What IP Disputes in Healthcare Are Likely to Emerge?
Munck Wilson Mandala Partner Greg Howison shared his perspective on some of the legal ramifications around AI, IP, connected devices and the data they generate, in response to emailed questions.
